EFTA01521333

GHISLAINE MAXWELL ACCT. For the Period 8/1/12 to 8/31/12 Equity Summary Beginning Ending Change Current Asset Categories Asset Categories Market Value Market Value In Value Allocation US Large Cap Equity 54,327.28 54,565.93 238.65 1% US Small/Mkt Cap Equity 5,160.00 8,280.00 3,120.00 1% Non-US Equity 138.50 130.36 (8.15) 1% Preferred Stocks 444,730.00 448,809.00 2,079.00 5% Prolenfl Stocks Concentrated 8 Other Equity 198.494.00 202,986.00 4,492.00 2% Nori-US Equity Total Value 5702,849.78 5712,771.28 $9,921.50 10% US Smalllitd Cap Equety Current Market Value/Cost Period Value US Large Cap Equity Market Value 712,771.28 Tax Cost 764,967.39 Concentrated 6 Other Equty Unrealized Gain/Loss (52,196.11) Estimated Annual Income 45,693.48 Equity as a percentage of your portfolio - 10 % Accrued Dividends 4,611.62 Yield 6.39% Equity Detail Adjusted Tax Cost Unrealized Est. Annual Inc. Price Quantity Value Original Cost Gain/Loss Accrued Dlv. Yield US Large Cap Equity APACHE CORP 85.75 95.000 8,146.25 11,403.30 (3,257.05) 64.60 0.79% 037411-10-5 APA JP Morgan Page 5 of 28 Confidential Treatment Requested by JPMorgan JPM-SDNY-00048710 Chase CONFIDENTIAL SDNY_GM_00317908 EFTA01521333